IODIXANOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Iodixanol, and what generic alternatives are available?
Iodixanol is a drug marketed by Hengrui Pharma and is included in one NDA.
The generic ingredient in IODIXANOL is iodixanol. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iodixanol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iodixanol
A generic version of IODIXANOL was approved as iodixanol by HENGRUI PHARMA on May 19th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IODIXANOL?
- What are the global sales for IODIXANOL?
- What is Average Wholesale Price for IODIXANOL?
Summary for IODIXANOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 37 |
| Patent Applications: | 3,931 |
| DailyMed Link: | IODIXANOL at DailyMed |
Recent Clinical Trials for IODIXANOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institute of Liver and Biliary Sciences, India | N/A |
| University of Washington | Phase 1 |
| Guerbet | Phase 1 |
Pharmacology for IODIXANOL
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for IODIXANOL
US Patents and Regulatory Information for IODIXANOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hengrui Pharma | IODIXANOL | iodixanol | INJECTABLE;INJECTION | 214271-001 | May 19, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hengrui Pharma | IODIXANOL | iodixanol | INJECTABLE;INJECTION | 214271-002 | May 19, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
